Tsung-Hui Hu (T-H Hu, Tsung H Hu)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 27

Top Topics

Ejection Fraction

Clinical Practice

Top Venues

Alimentary pharmacology & therapeutics

Scientific reports

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Chien-Hung Chen, Cheng-Yuan Peng, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu
Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics (2023)
Tzu-Ning Tseng, Wen-Juei Jeng, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu, Chien-Hung Chen
Combined baseline HBcrAg and end-of-treatment HBsAg predict HBV relapse after entecavir or tenofovir cessation. The Journal of antimicrobial chemotherapy (2022)
Pao-Yuan Huang, Sherry Yueh-Hsia Chiu, Kuo-Chin Chang, Po-Lin Tseng, Yi-Hao Yen, Ming-Chao Tsai, Jing-Houng Wang, Kwong-Ming Kee, Chien-Hung Chen, Chao-Hung Hung, King-Wah Chiu, Tsung-Hui Hu
A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir. Hepatology international 15 (2) (2021)
Chen Chien-Hung, Cheng-Yuan Peng, Yuan-Hung Kuo, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu
Earlier and higher rate of hepatitis B virus relapse after discontinuing tenofovir versus entecavir in HBeAg-positive patients. The Journal of infectious diseases (2021)
Sherry Yueh-Hsia Chiu, Kuo-Chin Chang, Tsung-Hui Hu, Rong-Nan Chien
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis-authors' reply. Alimentary pharmacology & therapeutics 53 (9) (2021)
Tzu-Hsin Huang, Ming-Tsung Lin, Jing-Houng Wang, Kuo-Chin Chang, Yi-Hao Yen, Fang-Ying Kuo, Chao-Cheng Huang, Chang-Chun Hsiao, Sherry Yueh-Hsia Chiu, Sheng-Nan Lu, Chih-Chi Wang, Tsung-Hui Hu
Clinical and novel application of FibroScan, FIB-4 and aspartate aminotransferase-to-platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction. International journal of clinical practice 75 (4) (2021)
Chun-Jen Liu, I-Shyan Sheen, Chi-Yi Chen, Wan-Long Chuang, Horng-Yuan Wang, Kuo-Chih Tseng, Ting-Tsung Chang, Jenny Yang, Benedetta Massetto, Vithika Suri, Gregory Camus, Deyuan Jiang, Fangqiu Zhang, Anuj Gaggar, Tsung-Hui Hu, Yu-Chun Hsu, Gin-Ho Lo, Chi-Jen Chu, Jyh-Jou Chen, Cheng-Yuan Peng, Rong-Nan Chien, Pei-Jer Chen
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up 108 Weeks Posttreatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Tsung-Hui Hu, Sherry Yueh-Hsia Chiu, Po-Lin Tseng, Chien-Hung Chen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Kwong-Ming Kee, Ming-Tsung Lin, Kuo-Chin Chang, Meng-Chih Lin, Rong-Nan Chien
Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Jia-Horng Kao, Tsung-Hui Hu, Ji-Dong Jia, Masayuki Kurosaki, Young Suk Lim, Han-Chieh Lin, Dong Hyun Sinn, Yasuhito Tanaka, Vincent Wai-Sun Wong, Man Fung Yuen
East Asia expert opinion on treatment initiation for chronic hepatitis B. Alimentary pharmacology & therapeutics 52 (10) (2020)
Wen-Nan Chiu, Chao-Hung Hung, Sheng-Nan Lu, Mei-Yen Chen, Shui-Yi Tung, Kuo-Liang Wei, Chung-Kuang Lu, Chien-Hung Chen, Tsung-Hui Hu, Jin-Hung Hu, Wei-Ming Chen, Te-Sheng Chang
Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan. Journal of viral hepatitis 27 (9) (2020)
Yi-Hao Yen, Yu-Fan Cheng, Jing-Houng Wang, Chih-Che Lin, Yen-Yang Chen, Chee-Chien Yong, Yueh-Wei Liu, Jen-Yu Cheng, Chien-Hung Chen, Tsung-Hui Hu
Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West. PloS one 15 (3) (2020)
Wei-Ru Cho, Chao-Hung Hung, Chien-Hung Chen, Chih-Che Lin, Chih-Chi Wang, Yueh-Wei Liu, Yi-Ju Wu, Chee-Chien Yong, Kuang-Den Chen, Yu-Chieh Tsai, Tsung-Hui Hu, Ming-Chao Tsai
Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery. Scientific reports 10 (1) (2020)
Chris Estes, Henry Lik Yuen Chan, Rong-Nan Chien, Wan-Long Chuang, James Yan-Yue Fung, George Boon-Bee Goh, Tsung-Hui Hu, Jee-Fu Huang, Byoung Kuk Jang, Dae Won Jun, Jia-Horng Kao, Jin-Woo Lee, Han-Chieh Lin, Kathryn Razavi-Shearer, Wai Kay Seto, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Homie Razavi
Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply. Alimentary pharmacology & therapeutics 51 (12) (2020)
Yi-Hao Yen, Kwong-Ming Kee, Chien-Hung Chen, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung
Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C. PloS one 14 (1) (2019)
Chun-Hsien Chen, Chien-Hung Chen, Chih-Lang Lin, Yung-Chang Lin, Tsung-Hui Hu, Shui-Yi Tung, Sen-Yung Hsieh, Sheng-Nan Lu, Rong-Nan Chien, Chao-Hung Hung, I-Shyan Sheen
Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis. Scientific reports 9 (1) (2019)
Ming-Chao Tsai, Yung-Chang Lin, Chao-Hung Hung, Sheng-Nan Lu, Shui-Yi Tung, Rong-Nan Chien, Chih-Lang Lin, Jing-Houng Wang, Chen Chien-Hung, Kuo-Chin Chang, Tsung-Hui Hu, I-Shyan Sheen
Evolution of renal function under direct-acting antivirals treatment for chronic hepatitis C: A real-world experience. Journal of viral hepatitis 26 (12) (2019)
Yi-Hao Yen, Chien-Hung Chen, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Kwong-Ming Kee, Tsung-Hui Hu
Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data. PloS one 14 (10) (2019)
Ming-Chao Tsai, Yi-Hao Yen, Kuo-Chin Chang, Chao-Hung Hung, Chien-Hung Chen, Ming-Tsung Lin, Tsung-Hui Hu
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection. BMC cancer 19 (1) (2019)
Chien-Hung Chen, Yao-Chun Hsu, S-N Lu, C-H Hung, J-H Wang, C-M Lee, Tsung-Hui Hu
The incidence and predictors of HBV relapse after cessation of tenofovir therapy in chronic hepatitis B patients. Journal of viral hepatitis 25 (5) (2018)
Yi-Hao Yen, Fang-Ying Kuo, Kwong-Ming Kee, Kuo-Chin Chang, Ming-Chao Tsai, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen
APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level. PloS one 13 (6) (2018)
King-Wah Chiu, Shigeru Goto, Toshiaki Nakano, Tsung-Hui Hu, Ding-Wei Chen, Kuang-Tzu Huang, Li-Wen Hsu, Chao-Long Chen
Genetic polymorphisms of the hepatic pathways of fatty liver disease after living donor liver transplantation. Liver international : official journal of the International Association for the Study of the Liver 38 (12) (2018)
Ming-Te Kuo, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Kai-Lung Tsai, Chien-Hung Chen
Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir. Alimentary pharmacology & therapeutics 49 (2) (2018)
Hung-Hsien Chiang, Chuan-Mo Lee, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Cheng-Yuan Peng, Chien-Hung Chen
A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir. Liver international : official journal of the International Association for the Study of the Liver 38 (11) (2018)
Kung-Hao Liang, Sang Hoon Ahn, Hye Wong Lee, Ya-Hui Huang, Rong-Nan Chien, Tsung-Hui Hu, Kwang-Huei Lin, Christopher Sung-Huan Yeh, Chao-Wei Hsu, Chih-Lang Lin, Tai-Long Pan, Po-Yuan Ke, Ming-Ling Chang, Chau-Ting Yeh
A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study. Scientific reports 8 (1) (2018)
Yi-Hao Yen, Jin-Bor Chen, Ben-Chung Cheng, Jung-Fu Chen, Kuo-Chin Chang, Po-Lin Tseng, Cheng-Kun Wu, Ming-Chao Tsai, Ming-Tsung Lin, Tsung-Hui Hu
Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study. PloS one 12 (4) (2017)
Chih-Chien Yao, Chao-Hung Hung, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Hung Wang, Chung-Mo Lee, Chien-Hung Chen
Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL. Scientific reports 7 (1) (2017)
Yi-Hao Yen, Ming-Tsung Lin, Fang-Ying Kuo, Kuo-Chin Chang, Ming-Chao Tsai, Po-Lin Tseng, Cheng-Kun Wu, Jung-Ting Lin, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen
The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients. Liver international : official journal of the International Association for the Study of the Liver 38 (6) (2017)